Stocks · Korea
206650
KOSDAQ
EuBiologics
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER7.53x
PBR1.78x
EPS1,127 KRW
BPS4,782 KRW
ROE16.27%
Dividend yield0.00%
DPS0 KRW
Payout ratio0.00%
Returns and 52-week range
1W+3.86%
1M-1.04%
3M-1.26%
6M-38.70%
1Y-39.14%
YTD-24.63%
52W high17,700원
52W low6,950원
From 52W high-51.41%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2021 | 394억 | -72억 | -280억 | -18.4% |
| 2022 | 555억 | -38억 | -34억 | -6.8% |
| 2023 | 694억 | 77억 | -154억 | 11.1% |
| Quarterly | ||||
| 2022 3Q | 128억 | -10억 | -2억 | -7.5% |
| 2022 4Q | 174억 | -31억 | -36억 | -17.6% |
| 2023 1Q | 144억 | -5억 | -5억 | -3.1% |
| 2023 2Q | 166억 | 20억 | 16억 | 12.0% |
| 2023 3Q | 114억 | -33억 | -34억 | -28.9% |
| 2023 4Q | 269억 | 95억 | -130억 | 35.2% |
Company
Address: 서울특별시 강남구 도산대로 509 13층,15층
Peers in the same sector
Recent filings
- 2026-08-21주요사항보고서(자기주식취득신탁계약해지결정) Major
- 2026-08-13반기보고서 (2026.06)
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.